1.

2.

3. Thiboutot DM, Strauss JS. 2003. Disease of Sebaceous Gland. In: Fitzpatrick’s

Dermatology in General Medicine 6th edition, Vol I. (Freedenberg, I.M, Eisen, A.Z, Wolff

K, Austen K.F, Goldsmith, L.A, and Katz S.I, eds.). New York: McGraw-Hill. p.765-781.

4. Baumann L, Keri J. 2009. Acne (Type 1 Sensitive Skin). In: Baumann, L. Cosmetic

Dermatology. 2nd Ed. New York: McGraw-Hill. p. 121-7.

5. Zouboulis CC, Eady A, Philpott M, Goldsmith LA, Orfanos C, Cunlife WC,

Rosenfield R. 2005. What is the Pathogenesis of Acne?. Exp Dermatol. 14: 143-52.

6. Wolf K, Johnson RA. 2009. Disorders of Sebaceous and Apocrine Glands. In: Fitzpatrick’s

Color Atlas & Synopsis of Clinical Dermatology. 6th Ed. New York: McGraw-Hill

Medical. p. 2-8.

7. Contassot E, French LE. 2014. New insights Acne Pathogenesis : Propionibacterium acnes

activates the inflammasome. Journal of Investigate Dermatology. 134: 310-313

8. Bruggemann H. 2005. Insights in the Pathogenic Potential of Propionibacterium

acnes From Its Complete Genome. Semin Cutan Med Surg. 24: 67-72.

9. Rathi SK. 2011. Acne Vulgaris Treatment : the current scenario. Indian J Dermatol.

56(1): 7-13

10. Draelos ZD. 2011. Acne and Cosmetics. In: Cosmetics and Dermatological Problem and

Solution.3rd ed. London: Informa Healthcare. p. 3-11

11.